Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Profit & Loss

Profit & Loss

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE71.285.32 (+8.07 %)
PREV CLOSE ( ) 65.96
OPEN PRICE ( ) 67.08
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1388
TODAY'S LOW / HIGH ( )66.49 72.00
52 WK LOW / HIGH ( ) 50.49106.78
Select year
(Rs.in Million)
Particulars
Mar 2025
Mar 2024
INCOME:
  
  
Operating Income
219.99
132.05
     Income from Medical Services
219.99
132.05
     Income from Diagnostic centre
     Pharmacy / Optical Income
     Less: Concession / Free Treatment
     Other Operational Income
0.00
0.00
Less: Excise Duty
Operating Income (Net)
219.99
132.05
EXPENDITURE :
Increase/Decrease in Stock
Cost of Medicines and Consumables
36.96
26.23
     Opening Raw Materials
4.47
3.99
     Purchases Raw Materials
37.60
26.71
     Closing Raw Materials
5.11
4.47
     Other Direct Purchases / Brought in cost
     Others raw material cost
0.00
0.00
Power & Fuel Cost
3.30
2.60
     Electricity & Power
3.30
2.60
     Oil, Fuel & Natural gas
0.00
0.00
     Coals etc
0.00
0.00
     Other power & fuel
0.00
0.00
Employee Cost
73.26
61.98
     Salaries, Wages & Bonus
68.23
57.06
     Contributions to EPF & Pension Funds
2.62
2.56
     Workmen and Staff Welfare Expenses
0.73
0.87
     Other Employees Cost
1.68
1.49
Hospital Operation Expenses
30.78
17.01
     House Keeping Expenses
     Consultant / Inhouse Fees
     Upkeep & Maintainence
     Sub-contract/ Outsourced services
     Processing Charges
     Packing Material Consumed
     Repairs and Maintenance
2.71
2.23
     Other Operating Expenses
28.07
14.79
Selling, Administration and Other Expenses
36.68
34.05
     Rent , Rates & Taxes
0.36
0.49
     Insurance
0.16
0.22
     Printing and stationery
3.14
1.98
     Professional and legal fees
11.33
10.95
     Advertisement & Sales Promotion
2.33
2.66
     Brokerage, Commissions & Incentives
     Freight outwards
8.12
8.42
     Other Administration expenses
11.24
9.33
Miscellaneous Expenses
3.77
2.05
     Bad debts /advances written off
     Provision for doubtful debts
3.34
1.82
     Losson disposal of fixed assets(net)
0.32
     Losson foreign exchange fluctuations
     Losson sale of non-trade current investments
     Other Miscellaneous Expenses
0.11
0.23
Less: Expenses Capitalised
Total Expenditure
184.74
143.92
Operating Profit (Excl OI)
35.25
-11.87
Other Income
3.89
4.21
     Interest Received
3.69
3.99
     Dividend Received
     Profit on sale of Fixed Assets
     Profits on sale of Investments
     Foreign Exchange Gains
     Provision Written Back
     Others
0.20
0.22
Operating Profit
39.14
-7.66
Interest
3.47
3.68
     InterestonDebenture / Bonds
     Interest on Term Loan
     Intereston Fixed deposits
     Bank Charges etc
0.42
0.51
     Other Interest
3.05
3.17
PBDT
35.66
-11.34
Depreciation
14.94
15.39
Profit Before Taxation & Exceptional Items
20.73
-26.72
Exceptional Income / Expenses
Profit Before Tax
20.23
-26.72
Provision for Tax
     Current Income Tax
     Deferred Tax
     Other taxes
0.00
0.00
Profit After Tax
20.23
-26.72
Extra items
0.00
0.00
Minority Interest
Share of Associate
Other Consolidated Items
Consolidated Net Profit
20.23
-26.72
Adjustments to PAT
Profit Balance B/F
-141.10
-115.03
Appropriations
-120.87
-141.75
     General Reserves
     Proposed Equity Dividend
     Corporate dividend tax
     Other Appropriation
0.00
-0.65
Equity Dividend %
Earnings Per Share
1.97
-2.60
Adjusted EPS
1.97
-2.60
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.